Skip to main content

Table 4 Total healthcare cost per month by baseline phosphate, Hungary, Italy, Portugal, Spain, and Turkey

From: Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study

 

Baseline phosphate*, mmol/mL

Total

< 1.13

≥ 1.13 – ≤ 1.78

> 1.78

Missing

 

N patients

827

3104

1208

247

5386

Total cost per month (including patients with zero costs), 2006 €

  Mean

62.02

75.27

88.88

66.60

75.89

  SD

176.01

273.40

145.08

147.07

231.52

  Median

15.24

26.66

46.00

28.57

28.61

  Q1, Q3

4.48, 54.32

8.51, 82.41

14.49, 107.77

10.65, 72.60

8.55, 83.69

  Min, Max

0.00, 3790.69

0.00, 9533.54

0.00, 2031.16

0.00, 1766.00

0.00, 9533.54

Patients with cost per month > €0, n (%)

732 (89)

2856 (92)

1116 (92)

234 (95)

4938 (92)

Cost of hospitalisations per month (including patients with zero costs), 2006 €

  Mean

24.81

22.53

17.87

25.05

21.95

  SD

165.02

264.57

111.07

142.43

219.56

  Median

0.00

0.00

0.00

0.00

0.00

  Q1, Q3

0.00, 0.00

0.00, 0.00

0.00, 0.00

0.00, 0.00

0.00, 0.00

  Min, Max

0.00, 3790.69

0.00, 9533.54

0.00, 1879.98

0.00, 1766.00

0.00, 9533.54

Patients with hospitalisation cost per month > €0, n (%)

50 (6)

130 (4)

60 (5)

14 (6)

254 (5)

Cost of medications per month (including patients with zero costs), 2006 €

  Mean

37.21

52.74

71.01

41.55

53.94

  SD

60.95

69.83

87.04

44.81

72.70

  Median

13.45

24.96

41.28

27.11

26.02

  Q1, Q3

3.89, 45.32

8.12, 74.40

13.37, 95.17

10.57, 62.62

8.04, 74.56

  Min, Max

0.00, 549.78

0.00, 709.97

0.00, 676.07

0.00, 365.41

0.00, 709.97

Patients with medication cost per month > €0, n (%)

727 (88)

2848 (92)

1112 (92)

233 (94)

4920 (91)

  1. *Mean phosphate during 3-month baseline period.